<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03856788</url>
  </required_header>
  <id_info>
    <org_study_id>GCO 18-1886</org_study_id>
    <nct_id>NCT03856788</nct_id>
  </id_info>
  <brief_title>Unilateral TAP Block for Laparoscopic Gastric Sleeve Surgery</brief_title>
  <official_title>Effect of Unilateral Ultrasound-Guided Subcostal Transversus Abdominis Plane Block in Patients Undergoing Laparoscopic Sleeve Gastrectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Icahn School of Medicine at Mount Sinai</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Icahn School of Medicine at Mount Sinai</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study team will be assessing if the unilateral subcostal transversus abdominis plane
      (TAP) block can decrease pain and improve outcomes following laparoscopic sleeve gastrectomy
      surgeries.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will be a double-blinded randomized control trial. Patients will be randomized
      into one of two groups. Patients in Group 1 will undergo general anesthesia with a
      post-induction, post-intubation, pre-procedural subcostal TAP block with 40 mL 0.25%
      bupivacaine on the ipsilateral side as the extraction site. Patients in Group 2 will undergo
      general anesthesia with a post-induction, post-intubation, pre-procedural subcostal TAP block
      with 40 mL sterile normal saline on the ipsilateral side as the extraction site.
      Investigators will be blinded to the randomization of these patients. Following performance
      of these blocks, patients will receive standard care for the surgery as well as during the
      postoperative recovery period. Data will be obtained from the EPIC electronic medical record,
      and from the anesthesia computer record. Patients will be asked postoperatively to assess
      items such as their nausea and pain scores. Patients will also be contacted by phone within
      1-2 days of discharge to obtain analgesic satisfaction scores. This data will be collected on
      the Redcap server.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 10, 2018</start_date>
  <completion_date type="Anticipated">February 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>The study consists of two study arms. Patients will be getting a subcostal transversus abdominis plane block with either bupivacaine or saline.</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
    <masking_description>Group allocation and instructions on preparing the injectate solution for the subcostal TAP block will be included in a sealed envelope. On the day of the surgery, the group allocation will be revealed to an anesthesiologist not involved with the research study. The anesthesiologist not involved in the study or the care of the patient will prepare the solution to be used for the subcostal TAP block.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Amount of 24 hour opioid consumption</measure>
    <time_frame>24 Hours</time_frame>
    <description>Amount of intravenous (IV) opioid consumption within 24-hour period</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Amount of intraoperative IV opioid consumption</measure>
    <time_frame>average 2-3 Hours</time_frame>
    <description>Amount of intravenous opioid consumption during the surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Amount of post-operative IV opioid consumption</measure>
    <time_frame>average 2 Days</time_frame>
    <description>Amount of intravenous opioid consumption after the surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Score</measure>
    <time_frame>up to 24 Hours</time_frame>
    <description>11-point numeric pain score Likert scale, full scale from 0-10, with higher score indicating more pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to breakthrough pain after surgery</measure>
    <time_frame>24 Hours</time_frame>
    <description>The time after surgery to which the patients require their first dose of opioid pain medication.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Area of pain on the body after surgery</measure>
    <time_frame>24 Hours</time_frame>
    <description>Patients will be asked for the areas of pain (right upper quadrant, left upper quadrant, right lower quadrant, or left lower quadrant) after surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence of postoperative nausea</measure>
    <time_frame>24 Hours</time_frame>
    <description>Compare presence of nausea after surgery. (yes/no)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analgesia satisfaction score at end of hospital stay</measure>
    <time_frame>average 1 Week</time_frame>
    <description>The analgesia satisfaction score after hospital discharge. Likert scale, full scale from 1-10, with higher score indicating more satisfaction with their analgesia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital length of stay</measure>
    <time_frame>average 3 Days</time_frame>
    <description>Length of hospital stay.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Laparoscopic Sleeve Gastrectomy</condition>
  <condition>Subcostal Transversus Abdominis Plane Block</condition>
  <arm_group>
    <arm_group_label>Saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients will undergo general anesthesia with a post-induction, post-intubation, pre-procedural subcostal TAP block with normal saline on the ipsilateral side as the extraction site.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bupivacaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will undergo general anesthesia with a post-induction, post-intubation, pre-procedural subcostal TAP block with bupivacaine on the ipsilateral side as the extraction site.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline</intervention_name>
    <description>40 mL sterile normal saline</description>
    <arm_group_label>Saline</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine</intervention_name>
    <description>40 mL 0.25% bupivacaine</description>
    <arm_group_label>Bupivacaine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults 18-80 years old

          -  Candidate for general anesthesia

          -  Undergoing laparoscopic sleeve gastrectomy

          -  Patients of participating surgeons

        Exclusion Criteria:

          -  Prior bariatric surgery of any kind

          -  Previous abdominoplasty

          -  Allergy or intolerance to one of the study medications

          -  ASA &gt; 4

          -  Chronic opioid use (taking opioids for longer than 3 months or daily oral morphine
             equivalent of &gt;5mg/day for one month)

          -  History of alcohol/drug abuse

          -  History of hepatic or renal insufficiency

          -  Patient refusal
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christina Jeng, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Icahn School of Medicine at Mount Sinai</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>James Leader, MPA</last_name>
    <phone>(212) 241-5468</phone>
    <phone_ext>x45468</phone_ext>
    <email>James.Leader@mountsinai.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Mount Sinai Brooklyn</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>11217</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James Leader, MPA</last_name>
      <phone>212-241-5468</phone>
      <phone_ext>x45468</phone_ext>
      <email>James.Leader@mountsinai.org</email>
    </contact>
    <investigator>
      <last_name>Christina Jeng, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.nysora.com/ultrasound-guided-transversus-abdominis-plane-quadratus-lumborum-blocks</url>
    <description>Subcostal TAP Block</description>
  </link>
  <reference>
    <citation>Thorell A, MacCormick AD, Awad S, Reynolds N, Roulin D, Demartines N, Vignaud M, Alvarez A, Singh PM, Lobo DN. Guidelines for Perioperative Care in Bariatric Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations. World J Surg. 2016 Sep;40(9):2065-83. doi: 10.1007/s00268-016-3492-3. Review.</citation>
    <PMID>26943657</PMID>
  </reference>
  <reference>
    <citation>Ruiz-Tovar J, Muñoz JL, Gonzalez J, Zubiaga L, García A, Jimenez M, Ferrigni C, Durán M. Postoperative pain after laparoscopic sleeve gastrectomy: comparison of three analgesic schemes (isolated intravenous analgesia, epidural analgesia associated with intravenous analgesia and port-sites infiltration with bupivacaine associated with intravenous analgesia). Surg Endosc. 2017 Jan;31(1):231-236. doi: 10.1007/s00464-016-4961-3. Epub 2016 May 13.</citation>
    <PMID>27177956</PMID>
  </reference>
  <reference>
    <citation>Cho JS, Kim HI, Lee KY, Son T, Bai SJ, Choi H, Yoo YC. Comparison of the effects of patient-controlled epidural and intravenous analgesia on postoperative bowel function after laparoscopic gastrectomy: a prospective randomized study. Surg Endosc. 2017 Nov;31(11):4688-4696. doi: 10.1007/s00464-017-5537-6. Epub 2017 Apr 7.</citation>
    <PMID>28389801</PMID>
  </reference>
  <reference>
    <citation>Abdelsalam K, Mohamdin OW. Ultrasound-guided rectus sheath and transversus abdominis plane blocks for perioperative analgesia in upper abdominal surgery: A randomized controlled study. Saudi J Anaesth. 2016 Jan-Mar;10(1):25-8. doi: 10.4103/1658-354X.169470.</citation>
    <PMID>26955306</PMID>
  </reference>
  <reference>
    <citation>Moncada R, Martinaitis L, Landecho M, Rotellar F, Sanchez-Justicia C, Bellver M, de la Higuera M, Silva C, Osés B, Martín E, Pérez S, Hernandez-Lizoain JL, Frühbeck G, Valentí V. Does Preincisional Infiltration with Bupivacaine Reduce Postoperative Pain in Laparoscopic Bariatric Surgery? Obes Surg. 2016 Feb;26(2):282-8. doi: 10.1007/s11695-015-1761-0.</citation>
    <PMID>26084250</PMID>
  </reference>
  <reference>
    <citation>Tsai HC, Yoshida T, Chuang TY, Yang SF, Chang CC, Yao HY, Tai YT, Lin JA, Chen KY. Transversus Abdominis Plane Block: An Updated Review of Anatomy and Techniques. Biomed Res Int. 2017;2017:8284363. doi: 10.1155/2017/8284363. Epub 2017 Oct 31. Review.</citation>
    <PMID>29226150</PMID>
  </reference>
  <reference>
    <citation>McDonnell JG, O'Donnell B, Curley G, Heffernan A, Power C, Laffey JG. The analgesic efficacy of transversus abdominis plane block after abdominal surgery: a prospective randomized controlled trial. Anesth Analg. 2007 Jan;104(1):193-7. Erratum in: Anesth Analg. 2007 May;104(5):1108.</citation>
    <PMID>17179269</PMID>
  </reference>
  <reference>
    <citation>Shibata Y, Sato Y, Fujiwara Y, Komatsu T. Transversus abdominis plane block. Anesth Analg. 2007 Sep;105(3):883; author reply 883.</citation>
    <PMID>17717265</PMID>
  </reference>
  <reference>
    <citation>Lee TH, Barrington MJ, Tran TM, Wong D, Hebbard PD. Comparison of extent of sensory block following posterior and subcostal approaches to ultrasound-guided transversus abdominis plane block. Anaesth Intensive Care. 2010 May;38(3):452-60.</citation>
    <PMID>20514952</PMID>
  </reference>
  <reference>
    <citation>Arı DE, Ar AY, Karip CS, Köksal C, Aydın MT, Gazi M, Akgün F. Ultrasound-guided subcostal-posterior transversus abdominis plane block for pain control following laparoscopic sleeve gastrectomy. Saudi Med J. 2017 Dec;38(12):1224-1229. doi: 10.15537/smj.2017.12.21133.</citation>
    <PMID>29209672</PMID>
  </reference>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>February 20, 2019</study_first_submitted>
  <study_first_submitted_qc>February 26, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 27, 2019</study_first_posted>
  <last_update_submitted>May 21, 2020</last_update_submitted>
  <last_update_submitted_qc>May 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 26, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Icahn School of Medicine at Mount Sinai</investigator_affiliation>
    <investigator_full_name>Christina Jeng</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Randomized control trial</keyword>
  <keyword>Subcostal transversus abdominis plane block</keyword>
  <keyword>Laparoscopic sleeve gastrectomy</keyword>
  <keyword>Regional anesthesia</keyword>
  <keyword>Opioid consumption</keyword>
  <keyword>Bariatrics</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

